Medtronic Neuromodulation recalls Enhanced Verify Evaluation Handset (CFN HH90130FA)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.
- Products
-
- Enhanced Verify Evaluation Handset (CFN HH90130FA)
- Company
- Medtronic Neuromodulation
- Where it was sold
-
US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, LA, MA, MD, MI, MN, MS, NC, NE, NJ, NM, NY, OH, OR, PA, TX, WA, WI.
Nationwide
- Barcodes
00763000930042- Units affected
- 534
- About this recall
- Enhanced Verify Evaluation Handset (CFN HH90130FA)